MoonLake Immunotherapeutics (NAS:MLTX)
$ 55.47 1.04 (1.91%) Market Cap: 3.50 Bil Enterprise Value: 2.94 Bil PE Ratio: 0 PB Ratio: 7.17 GF Score: 22/100

MoonLake Immunotherapeutics Capital Markets Day Transcript

Apr 19, 2023 / 02:30PM GMT
Release Date Price: $21.85 (+0.32%)
Jorge Santos Da Silva
MoonLake Immunotherapeutics - CEO

So welcome to MoonLake's Capital Markets Day. For all of you joining us here in the room, a warm welcome. Thank you for spending the next couple of hours with us and what we hope and expect is an informative session for all of you. For the many of you joining us through our webcast platform, also a very warm welcome. Good morning, good afternoon, good evening, depending on where you're joining us from.

Today's session is part of our broader engagement with the market, with the investor community, the analyst community, the KOL community, all our communities. And it's a big pleasure for us to be here today. In today's session, we will not only be sharing with you some important updates, and importantly, some guidance associated with catalysts that are coming soon, but we will also be sharing some critical perspectives and new information, so that you can prepare yourselves as you think about us over the next couple of months for moments that we think are going to be decisive and key for MoonLake as a company.

In today's session, as

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot